LinXis is proud to welcome Professor Dario Neri to its Advisory BoardJuly 23, 2019
We are happy to welcome Professor Dario Neri to our Scientific Advisory Board. Professor Neri has extensive experience in antibody engineering for the therapy of cancer and other angiogenesis-related disorders.
Professor Neri is a co-founder of Philogen, a Swiss-Italian biotech company which has brought various antibody products into multi-center clinical trials for the treatment of cancer and of chronic inflammatory conditions.
We are more than certain that Professor Neri’s expertise will greatly support us in our mission to create effective, safe and affordable medicines for patients suffering from cancer or chronic liver disease.